We are a privately held company in the Twin Cities (MN) area founded in 2001 through a technology license with University of Minnesota. Our initial technology focused towards medical devices and advanced nano-scale coating processes within a busines-to-business ‘technology services' model.We recently reorganized and restructured to scale-up technology, generate macro-particles for oral-solid drug development. We have demonstrated a strong proof-of-concept in enhancing low solubility drug performance and solid progress across our target drug pipeline. Our product enhancements span patient safety, convenience, compliance and effectiveness that have been achieved by overcoming challenging insolubility issues, increasing bio-availability performance and dramatically reducing defects.Substantial investment from investors has made building a technically accomplished team and experienced industry management to create valuable 505(b)(2) opportunities a reality.